Navigation Links
GeoVax Labs, Inc. Comments on Discontinuance of Merck's HIV Vaccine Trial
Date:9/24/2007

p>

GeoVax AIDS vaccines are being prepared to enter Phase 2 human trials. These large trials will expand the safety and positive immune response data demonstrated in the five (5) prior GeoVax AIDS vaccine trial groups. These trials will be conducted in collaboration with the HIV Vaccine Trials Network.

On the basis of non-human primate studies, GeoVax believes its vaccines will be safe and protective. A rigorously conducted clinical trial in human volunteers will be accomplished to confirm effectiveness in preventing AIDS. With 14,000 new HIV/AIDS infections reported daily and more than 60 million people living with HIV/AIDS worldwide, the need for an effective HIV/AIDS vaccine is extremely urgent.

Note: The US Food and Drug Administration (FDA) has established and oversees the regulatory guidelines for clinical trials in the United States and requires regular reports on the progress of clinical trials. The HIV Vaccine Trials Network provides a unifying structure for trials of candidate HIV/AIDS vaccines.

About GeoVax Labs, Inc. (http://www.geovax.com)

GeoVax Labs, Inc. is a biotechnology company, established to develop, manufacture, license and commercialize human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents. GeoVax's vaccine technology is protected by 20 filed patent applications and issued patents.

GeoVax HIV/AIDS vaccines are designed to prevent development of Acquired Immunodeficiency Disease (AIDS), caused by the virus known as HIV-1, by vaccinating individuals prior to their infection with the AIDS virus. GeoVax vaccine regimens employ a "prime-boost" strategy where its DNA vaccine "primes" the immune response and is followed by administration of the GeoVax MVA (Modified Vaccinia Virus) booster vaccination. Both vaccines deliver over 50% of the AIDS virus components but cannot cause AIDS. In addition, GeoVax AIDS vaccines may b
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
3. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
4. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
5. Vaccine Can Prevent Cervical Cancer and Precancerous Lesions
6. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
7. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
8. HepaLifes PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference
9. New Flu Vaccine from PepTcell Could Provide Immunity Against All Strains of Influenza Virus
10. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
11. New Flu Vaccine From PepTcell Could Provide Immunity Against All Strains of Influenza Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014  Manufacturers, suppliers and distributors of ... to protect their most important business assets, intellectual ... ) Because of the highly-competitive nature ... one of the most litigious industry sectors of ...
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... developing its Symphony® CGM System as a non-invasive, wireless ... F. Doman , Executive Chairman and Interim CEO of ... Markets, Tenth Annual Equity Conference. Mr. ...
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: PharmaPoint: ... Market Analysis to 2022 ... - India Drug Forecast and Market Analysis ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5
(Date:4/18/2014)... could lead to potential new treatments for breaking the ... , Fibrosis, or scarring, is a hallmark of the ... can lead to serious organ damage and, in some ... centers on findings made by Swati Bhattacharyya, PhD, research ... a specific protein plays in promoting fibrosis. , ...
(Date:4/17/2014)... relief targets that could be used to provide ... College London made the discovery when researching how ... the body. , Dr Marzia Malcangio said: "We ... generation and our findings could help chemotherapy patients ... potential side effect of some chemotherapy drugs (such ...
(Date:4/17/2014)... the University of California, San Diego School of Medicine ... have suffered a recent major loss are more likely ... , The study is published in this month,s issue ... , Because compassionate behaviors are associated with better health ... insights into ways to improve the outcomes of individuals ...
(Date:4/17/2014)... University synthetic biology team has created a new ... therapeutics that could travel the body and selectively ... Engineering cell-based, biological devices that monitor and modify ... synthetic biology. However, no existing technology enabled bioengineers ... physiological state and respond in a customized fashion. ...
(Date:4/17/2014)... cause of neuronal death in Parkinson,s disease is still ... be mistaken for foreign invaders and killed by the ... diseases like type I diabetes, celiac disease, and multiple ... April 16, 2014, in Nature Communications . , ... Parkinson,s disease; but if true, it could lead to ...
Breaking Medicine News(10 mins):Health News:New clues on tissue scarring in scleroderma 2Health News:New pain relief targets discovered 2Health News:The ilk of human kindness 2Health News:Building 'smart' cell-based therapies 2Health News:Is Parkinson's an autoimmune disease? 2
... Association (NMA), the nation,s premier membership organization for ... amount of $120,000 from the W.K. Kellogg Foundation. ... grant commitment, designed "to promote health care coverage ... partner organizations."Partner organizations for this effort include Families ...
... in urban areas , , TUESDAY, April 21 (HealthDay News) -- ... areas are not less likely to get a kidney transplant ... , Researchers analyzed U.S. data on 699,751 adults with kidney ... 1995 and 2007. After about two years on the list, ...
... reduced risk of relapse or death, study finds , , ... lymphoma who drank wine before their diagnosis appeared to ... to a study that,s the first to identify this ... women with non-Hodgkin lymphoma and found that, overall, those ...
... your memory will get worse as you get older may ... University have found that senior citizens who think older people ... worse than seniors who do not buy in to negative ... published earlier this month, psychology professor Dr. Tom Hess and ...
... April 21 DaVita Inc. (NYSE: ... services for those diagnosed with chronic kidney disease ... as the company,s Senior Vice President of Federal ... public policy efforts in Washington, D.C. and report ...
... quality care needs in skilled nursing facilitiesCOLUMBUS, Ohio, ... Nursing Care Coalition, the umbrella group representing Ohio,s ... of the state budget bill unveiled by House ... services to Ohio,s frail elderly and disabled citizens ...
Cached Medicine News:Health News:National Medical Association Receives Funding From Kellogg for Training Community Advocates 2Health News:Distance No Bar to Kidney Transplants in Remote Areas 2Health News:Wine May Guard Against Lymphoma Recurrence 2Health News:Think memory worsens with age? Then yours probably will 2Health News:John Schaeffler Appointed Senior Vice President for Federal Legislative Affairs 2Health News:Skilled Nursing Care Coalition Praises House Leadership for Budget Changes 2
For the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma....
For the quantitative in vitro determination of Carbamazepine in human serum...
For the quantitative in vitro determination of Phenobarbital in human serum....
Determination of the Thrombin Time by STA Analyzers. Freeze-dried human thrombin (1.5NIH units/mL) with calcium....
Medicine Products: